Brightsurf Science News & Current Events

December 25, 2013
Rheumatoid arthritis research shows the potential of large-scale genetic studies for drug discovery
The results of the largest international study to date into the genetic basis of rheumatoid arthritis shed light on the biology of the disease and provide evidence that large-scale genetic studies can assist in the identification of new drugs for complex disorders such as rheumatoid arthritis.

Epigenetics enigma resolved
Scientists have obtained the first detailed molecular structure of a member of the Tet family of enzymes.

International team completes systematic, genomic study of cervical cancer
Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical cancer in two patient populations.

Special topic: Airworthiness and fatigue
Aviation safety is the theme given to the International Conference on Airworthiness and Fatigue: 7th ICSAELS Series Conference, Beijing, China, held on 25 March, 2013.

New genetic risk factor for type 2 diabetes revealed
An international team of researchers in Mexico and the United States has uncovered a new genetic clue that contributes to an increased risk of developing type 2 diabetes, particularly the elevated risk among Mexican and other Latin American populations.

Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis
An international group of investigators has discovered new genes, pathways and cell types that are involved in inherited susceptibility to rheumatoid arthritis.

Molecular markers used for assessment of early sciatic nerve injury
This release focuses on molecular markers used for assessment of early sciatic nerve injury.

Researcher says extensive use of antibiotics in agriculture creating public health crisis
Citing an overabundance in the use of antibiotics by the agriculture and aquaculture industries that poses a threat to public health, economics professor Aidan Hollis has proposed a solution in the form of user fees on the non-human use of antibiotics. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to